Attaining United States and European guideline LDL-C levels with simvastatin in patients with coronary heart disease (the GOALLS study).
Mikhailidis
D P
DP
Department of Molecular Pathology & Clinical Biochemistry, Royal Free and University College Medical School, Royal Free Campus, London NW3 2QG, UK.
Wierzbicki
A S
AS
D000924:Anticholesteremic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D008078:Cholesterol, LDL / Q000097:blood / Q000187:drug effects*; D003327:Coronary Disease / Q000097:blood / Q000150:complications; D005060:Europe; D019317:Evidence-Based Medicine; D017408:Guidelines as Topic; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D019821:Simvastatin / Q000494:pharmacology / Q000627:therapeutic use*; D014481:United States
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D019821:Simvastatin